1 terminated, 1 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 1, Withdrawn 1 |
Follow Valvular Heart Disease: new trials by email Literature Review of Valvular Heart Disease trials Research Report on Valvular Heart Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II Prolonged interval between PT testing - Atrial Fibrillation, Valvular Heart Disease | Phase 3 | Withdrawn | McMaster University | 2014-04-01 | 2014-03-20 | |
| MPAACS: Magnesium for the Prevention of Atrial Arrhythmias After Cardiac Surgery intravenous magnesium - Coronary Artery Disease, Valvular Heart Disease | Phase 3 | Terminated | University of British Columbia | 927 | 2004-07-01 | 2010-11-04 |
Heart Valve Diseases (2) · Atrial Fibrillation (1) · Coronary Artery Disease (1) · Hemorrhage (1) · Peripheral Arterial Disease (1) · Pulmonary Embolism (1) · Thromboembolism (1) · Venous Thrombosis (1)
Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Cardiovascular Diseases (2) · Heart Diseases (2) · Vascular Diseases (2) · Arrhythmias, Cardiac (1) · Atherosclerosis (1) · Coronary Disease (1) · Embolism (1) · Embolism and Thrombosis (1) · Lung Diseases (1) · Myocardial Ischemia (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Peripheral Vascular Diseases (1)
International Normalized Ratio (1)
McMaster University (1) · University of British Columbia (1)
Canada (2)
Hubert Wong, PhD (1) · Karin H Humphries, DSc (1) · Sam Schulman, MD, PhD (1)